LAB
Standard BioTools Inc. · Healthcare
Caligan Partners LP bought $1.4M of Standard BioTools Inc.
10% owner
Bought$1,406,715
$2.88Price
488,350Shares
+3%Stake
What LAB did for a copier
Prices for LAB after this filing aren't in yet.
Caligan Partners LP's record
6 other buys with 3 months of prices since 2022: on average +23.2% against the S&P 500, and 5 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, May 6. Filed Tue, May 10, 5:03 PM ET, after the close. Not investment advice.